AVITA Medical , a global regenerative medicine company, today announced that the results from two U.S. pivotal clinical trials demonstrating the effectiveness and clinical benefits of the RECELL Autologous Cell Harvesting Device were presented at the 46th Annual Eastern Great Lakes Burn Conference in Ann Arbor, Michigan.